NO146061C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner

Info

Publication number
NO146061C
NO146061C NO77771375A NO771375A NO146061C NO 146061 C NO146061 C NO 146061C NO 77771375 A NO77771375 A NO 77771375A NO 771375 A NO771375 A NO 771375A NO 146061 C NO146061 C NO 146061C
Authority
NO
Norway
Prior art keywords
iminothiazolines
iminothiazolidines
preparation
active derivatives
therapeutic active
Prior art date
Application number
NO77771375A
Other languages
English (en)
Norwegian (no)
Other versions
NO146061B (no
NO771375L (no
Inventor
Clarence Stanley Rooney
Joshua Rokach
Edward Jethro Cragoe Jr
George Gal
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO771375L publication Critical patent/NO771375L/no
Publication of NO146061B publication Critical patent/NO146061B/no
Publication of NO146061C publication Critical patent/NO146061C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/43Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO77771375A 1976-05-03 1977-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner NO146061C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68287676A 1976-05-03 1976-05-03

Publications (3)

Publication Number Publication Date
NO771375L NO771375L (no) 1977-11-04
NO146061B NO146061B (no) 1982-04-13
NO146061C true NO146061C (no) 1982-07-28

Family

ID=24741558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO77771375A NO146061C (no) 1976-05-03 1977-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner

Country Status (24)

Country Link
JP (1) JPS52133981A (da)
AU (1) AU508889B2 (da)
BE (1) BE854172A (da)
CA (1) CA1078846A (da)
CH (1) CH629490A5 (da)
DE (1) DE2719577A1 (da)
DK (1) DK173777A (da)
ES (2) ES458237A1 (da)
FI (1) FI771285A (da)
FR (1) FR2350351A1 (da)
GB (1) GB1534242A (da)
HU (1) HU180504B (da)
IE (1) IE46011B1 (da)
IL (1) IL51935A (da)
IT (1) IT1082657B (da)
LU (1) LU77243A1 (da)
NL (1) NL7704322A (da)
NO (1) NO146061C (da)
NZ (1) NZ183941A (da)
PH (1) PH14030A (da)
PL (1) PL123449B1 (da)
SE (1) SE7704594L (da)
YU (1) YU111677A (da)
ZA (1) ZA772614B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US5555162A (en) * 1994-04-26 1996-09-10 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
USRE37310E1 (en) 1994-12-06 2001-08-07 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
FR2748023B1 (fr) 1996-04-30 1998-07-24 Rhone Poulenc Chimie Hydrogenofluorosulfonates de base organique, leur utilisation pour liberer les bases organiques de leur fluorhydrate, leur procede de preparation, compositions les comportant

Also Published As

Publication number Publication date
NO146061B (no) 1982-04-13
BE854172A (fr) 1977-11-03
HU180504B (en) 1983-03-28
ES458237A1 (es) 1978-07-01
CA1078846A (en) 1980-06-03
NO771375L (no) 1977-11-04
PL123449B1 (en) 1982-10-30
FR2350351B1 (da) 1979-03-02
IL51935A (en) 1981-07-31
IE46011B1 (en) 1983-01-26
PH14030A (en) 1980-12-12
ZA772614B (en) 1978-12-27
NL7704322A (nl) 1977-11-07
JPS52133981A (en) 1977-11-09
AU508889B2 (en) 1980-04-03
NZ183941A (en) 1980-12-19
FI771285A (da) 1977-11-04
ES468377A1 (es) 1978-12-16
IL51935A0 (en) 1977-06-30
DK173777A (da) 1977-11-04
IE46011L (en) 1977-11-03
LU77243A1 (da) 1977-12-13
SE7704594L (sv) 1977-11-04
YU111677A (en) 1983-01-21
DE2719577A1 (de) 1977-11-24
AU2463077A (en) 1978-11-02
FR2350351A1 (fr) 1977-12-02
CH629490A5 (en) 1982-04-30
IT1082657B (it) 1985-05-21
GB1534242A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO150044C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO147750C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive og optisk aktive 11-desoksy-16-aryloksy-omega-tetranorprostaglandiner
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO146061C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner